Latigo Biotherapeutics

Last updated: June 13, 2024

CEO - Desmond Padhi
CEO - Desmond Padhi
USA | Funding: $150M (+)

Website: https://www.latigobio.com/

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.